Patents by Inventor Laurence Decrane

Laurence Decrane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyridinone and pyridinethione derivatives having HIV inhibiting properties
    Patent number: 7115608
    Abstract: The present invention is concerned among others with compounds of formula (1), the N-oxides, the pharmaceutically acceptable addition salts, the quaternary amines and stereochemically isomeric forms thereof, wherein Q is halo, C1-6 alkyl or C2-6 alkenyl; X is (a-2) with q and r being O and Z being O, S or SO; R1 is aryl; R2 is selected from formyl; C1-6alkyloxycarbonylalkyl; Het2; Het2C1-6alkyl, C1-6alkylthio; C1-6alkyl optionally substituted with one or two substituents each independently selected from hydroxy, and halo; R3 is selected from formyl; C1-6alkyl optionally substituted with one or two C1-6alkyloxy; R4 is hydrogen, with HTV inhibiting properties
    Type: Grant
    Filed: September 18, 2001
    Date of Patent: October 3, 2006
    Assignees: Centre National de la Recherche Schentifique, Institute Curie
    Inventors: Jérôme Guillemont, Abdellah Benjahad, Dominique Mabire, Chi Hung N'Guyen, David Grierson, Claude Monneret, Emile Bisagni, Gérard Sanz, Laurence Decrane
  • Pyridinone and pyridinethione derivatives having hiv inhibiting properties
    Publication number: 20040229847
    Abstract: The present invention is concerned among others with compounds of formula (I), the N-oxides, the pharmaceutically acceptable addition salts, the quaternary amines and stereochemically isomeric forms thereof, wherein Q is halo, C1-6 alkyl or C2-6 alkenyl; X is (a-2) with q and r being O and Z being O, S or SO; R1 is aryl; R2 is selected from formyl; C1-6alkyloxycarbonylalkyl; Het2; Het2C1-6alkyl, C1-6alkylthio; C1-6alkyl optionally substituted with one or two substituents each independently selected from hydroxy, and halo; R3 is selected from formyl; C1-6alkyl optionally substituted with one or two C1-6alkyloxy; R1 is hydrogen, with HTV inhibiting properties.
    Type: Application
    Filed: March 18, 2003
    Publication date: November 18, 2004
    Inventors: Jerome Guillemont, Abdellah Benjahad, Dominique Mabire, Chi Hung N'guyen, David Gierson, Claude Monneret, Emile Bisagni, Gerard Sanz, Laurence Decrane